Fgf21 variants
US-2025171512-A1 · May 29, 2025 · US
This page is not indexed by search engines while we improve data quality.
Langer Thomas patents
Langer Thomas is listed as an inventor on 27 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Langer Thomas |
| Total patents | 27 |
| First publication | Apr 9, 2015 |
| Latest publication | May 29, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
FGFR1/KLB Targeting Agonistic Antigen-Binding Proteins and Conjugates Thereof with GLP-1R Agonistic Peptides
US-2025115669-A1 · Apr 10, 2025 · US
Fgf21 compound / glp-1r agonist combinations with optimized activity ratio
US-2024366727-A1 · Nov 7, 2024 · US
FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptides
US-12054551-B2 · Aug 6, 2024 · US
Effectorless fc molecules
US-2024043522-A1 · Feb 8, 2024 · US
Pseudofab-based multispecific binding proteins
US-2023391888-A1 · Dec 7, 2023 · US
Multispecific antibodies facilitating selective light chain pairing
US-11820809-B2 · Nov 21, 2023 · US
Protease-processed molecules
US-2023279151-A1 · Sep 7, 2023 · US
PseudoFab-based multispecific binding proteins
US-11739160-B2 · Aug 29, 2023 · US
Glp-1r agonist / fgf21 fusion proteins
US-2023265152-A1 · Aug 24, 2023 · US
Recent patents
Latest publications not already listed above.
Glp-1r agonistic peptides with reduced activity
US-2023250147-A1 · Aug 10, 2023 · US
Split ch2 domains
US-2023103563-A1 · Apr 6, 2023 · US
Fgf21 compound / glp-1r agonist combinations with optimized activity ratio
US-2022401523-A1 · Dec 22, 2022 · US
Fgf21 variants
US-2022227825-A1 · Jul 21, 2022 · US
FGF21 variants
US-11230582-B2 · Jan 25, 2022 · US
FGFR1/KLB Targeting Agonistic Antigen-Binding Proteins and Conjugates Thereof with GLP-1R Agonistic Peptides
US-2022010021-A1 · Jan 13, 2022 · US
Fgf21 compound / glp-1r agonist combinations with optimized activity ratio
US-2020261542-A1 · Aug 20, 2020 · US
Pseudofab-based multispecific binding proteins
US-2020255540-A1 · Aug 13, 2020 · US
FGF21 compound / GLP-1R agonist combinations with optimized activity ratio
US-10583174-B2 · Mar 10, 2020 · US
Fusion proteins for treating a metabolic syndrome
US-2019085043-A1 · Mar 21, 2019 · US
Fgf21 variants
US-2018371041-A1 · Dec 27, 2018 · US
Fgf21 compound / glp-1r agonist combinations with optimized activity ratio
US-2018236037-A1 · Aug 23, 2018 · US
Multispecific Antibodies Facilitating Selective Light Chain Pairing
US-2018057567-A1 · Mar 1, 2018 · US
Double-wall pipe and production process
US-9458954-B2 · Oct 4, 2016 · US
Antagonist antibodies and their fab fragments against GPVI and uses thereof
US-9441040-B2 · Sep 13, 2016 · US
Fusion proteins comprising FGF-21 and GLP-1R agonist
US-2016194371-A1 · Jul 7, 2016 · US
Novel antagonist antibodies and their fab fragments against gpvi and uses thereof
US-2015098939-A1 · Apr 9, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Sanofi Sa | 26 |
| Airbus Operations Gmbh | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P3/10 | 15 |
| C07K2317/92 | 13 |
| C07K14/50 | 12 |
| C07K14/605 | 12 |
| A61K38/1825 | 12 |